Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated
<b>Background/Objective:</b> Millions of children were infected with SARS-CoV-2, and a small proportion progressed to severe disease, especially those with underlying risk factors. Adult COVID-19 studies showed mortality benefits with Remdesivir. Data on Remdesivir use in pediatrics are...
Saved in:
| Main Authors: | Delma J. Nieves, M. Tuan Tran, Jasjit Singh, Negar Ashouri, Tricia Morphew, Jennifer G. Lusk, Felice C. Adler-Shohet, Rachel Marano, Stephanie Osborne, Jennifer Strickland, Antonio C. Arrieta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9067/12/3/331 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunological Effects of Remdesivir on Colon Cancer Cell Line
by: Alaa Hameed, et al.
Published: (2025-04-01) -
Synthesis of Radioisotope 14C Labelled Remdesivir
by: Zhi-yang YU, et al.
Published: (2025-02-01) -
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?
by: Darius Babusis, et al.
Published: (2025-06-01) -
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
by: Alexander Simonis, et al.
Published: (2020-11-01) -
Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19
by: Mark Berry, et al.
Published: (2025-07-01)